Nerve ultrasound: A useful screening tool for peripheral nerve sheath tumors in NF1?

Neurology

Volumn 88, Issue 17, 2017, Pages 1615-1622

  Telleman, Johan A ^a   Stellingwerff, Menno D ^a   Brekelmans, Geert J ^a   Visser, Leo H ^a  

^a Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRACHIAL PLEXUS; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HIGH RESOLUTION ULTRASONOGRAPHY; HUMAN; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MIDDLE AGED; NERVE CONDUCTION; NEUROFIBROMATOSIS TYPE 1; PERIPHERAL NERVOUS SYSTEM; PILOT STUDY; PRIORITY JOURNAL; SCREENING TEST; YOUNG ADULT; COMPLICATION; INNERVATION; LOWER LIMB; NERVE SHEATH NEOPLASMS; PATHOPHYSIOLOGY; UPPER LIMB;

ADULT; AGED; BRACHIAL PLEXUS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; NERVE SHEATH NEOPLASMS; NEURAL CONDUCTION; NEUROFIBROMATOSIS 1; PILOT PROJECTS; ULTRASONOGRAPHY; UPPER EXTREMITY; YOUNG ADULT;

EID: 85019805468     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003870     Document Type: Article

References (28)

1. Hirbe AC, Gutmann DH. Neurofibromatosis type 1: A multidisciplinary approach to care. Lancet Neurol 2014;13:834-843.
2. Ferner RE, Hughes RA, Hall SM, Upadhyaya M, Johnson MR. Neurofibromatous neuropathy in neurofibromatosis 1 (NF1). J Med Genet 2004;41:837-841.
3. Drouet A, Wolkenstein P, Lefaucheur JP, et al. Neurofibromatosis 1-associated neuropathies: A reappraisal. Brain 2004;127:1993-2009.
4. Sbidian E, Bastuji-Garin S, Valeyrie-Allanore L, et al. Atrisk phenotype of neurofibromatose-1 patients: A multicentre case-control study. Orphanet J Rare Dis 2011;6:51.
5. Yerdelen D, Koc F, Durdu M, Karakas M. Electrophysiological findings in neurofibromatosis type 1. J Neurol Sci 2011;306:42-48.
6. Stucky CH, Johnson KN, Gray RJ, et al. Malignant peripheral nerve sheath tumors (MPNST): The Mayo Clinic experience. Ann Surg Oncol 2012;19:878-885.
7. Derlin T, Tornquist K, Munster S, et al. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Clin Nucl Med 2013; 38:e19-e25.
8. Salamon J, Mautner VF, Adam G, Derlin T. Multimodal imaging in neurofibromatosis type 1-associated nerve sheath tumors. Rofo 2015;187:1084-1092.
9. Ahlawat S, Fayad LM, Khan MS, et al. Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis. Neurology 2016;87:S31-S39.
10. Goedee HS, Brekelmans GJ, Asseldonk JT, Beekman R, Mess WH, Visser LH. High resolution sonography in the evaluation of the peripheral nervous system in polyneuropathy: A review of the literature. Eur J Neurol 2013;20: 1342-1351.
11. Reynolds DL Jr, Jacobson JA, Inampudi P, Jamadar DA, Ebrahim FS, Hayes CW. Sonographic characteristics of peripheral nerve sheath tumors. AJR Am J Roentgenol 2004;182:741-744.
12. Chen W, Jia JW, Wang JR. Soft tissue diffuse neurofibromas: sonographic findings. J Ultrasound Med 2007;26:513-518.
13. Hassell DS, Bancroft LW, Kransdorf MJ, et al. Imaging appearance of diffuse neurofibroma. AJR Am J Roentgenol 2008;190:582-588.
14. Song SE, Seo BK, Choi JW, Son GS, Cho KR, Kim BH. The sonographic "coffee bean" sign helps distinguish an axillary neurofibroma from a lymphadenopathy. J Clin Ultrasound 2014;42:33-37.
15. Neurofibromatosis. Conference statement. National Institute of Health Consensus Development Conference. Arch Neurol 1988;45:575-578.
16. Goedee HS, van der Pol WL, Asseldonk JT, et al. Nerve sonography to detect peripheral nerve involvement in vasculitis syndromes. Neurol Clin Pract Epub 2016 May 19.
17. Ryu JA, Lee SH, Cha EY, Kim TY, Kim SM, Shin MJ. Sonographic differentiation between schwannomas and neurofibromas in the musculoskeletal system. J Ultrasound Med 2015;34:2253-2260.
18. Tsai WC, Chiou HJ, Chou YH, Wang HK, Chiou SY, Chang CY. Differentiation between schwannomas and neurofibromas in the extremities and superficial body: The role of high-resolution and color Doppler ultrasonography. J Ultrasound Med 2008;27:161-166.
19. Gosein M, Ameeral A, Banfield R, Mosodeen M. Plexiform neurofibroma of the wrist: imaging features and when to suspect malignancy. Case Rep Radiol 2013; 2013:493752.
20. Visser LH, Goedee HS. The relation between nerve morphology detected by sonography and electrodiagnostic findings. Clin Neurophysiol 2014;125:1293-1294.
21. Ducatman BS, Scheithauer B, Piepgras DG, Reiman H, Ilstrup D. Malignant peripheral nerve sheath tumors: A clinicopathologic study of 120 cases. Cancer 1986;57: 2006-2021.
22. De Raedt T, Brems H, Wolkenstein P, et al. Elevated risk for MPNST in NF1 microdeletion patients. Am J Hum Genet 2003;72:1288-1292.
23. Nguyen R, Jett K, Harris GJ, Cai W, Friedman JM, Mautner VF. Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. J Neurooncol 2014;116:307-313.
24. Hagel C, Zils U, Peiper M, et al. Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors. J Neurooncol 2007;82: 187-192.
25. Plotkin SR, Bredella MA, Kassarjian A, et al. Quantitative assessment of whole body tumor burden in adult patients with neurofibromatosis. PLoS One 2012;7:e35711.
26. Tonsgard JH, Kwak SM, Short MP, Dachman AH. CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions. Neurology 1998;50: 1755-1760.
27. Chaduvula MV, Visser LH, Suneetha S, et al. Highresolution sonography as an additional diagnostic and prognostic tool to monitor disease activity in leprosy: A two-year prospective study. Ultraschall Med Epub 2016 Jun 7.
28. Lugão HB, Frade MA, Marques-Jr W, Foss NT, Noqueira-Barbosa MH. Ultrasonography of leprosy neuropathy: A longitudinal prospective study. PLoS Negl Trop Dis 2016;10:e0005111.